Literature DB >> 10655046

A bird's eye view of global methylation.

C Eng, J G Herman, S B Baylin.   

Abstract

Restriction landmark genomic scanning applied to a broad variety of cancer types can disclose tumour-specific and tumour-type-specific global methylation profiles. This and other genome-scanning approaches allows the rapid analysis of methylation profiles of thousands of genes in parallel-and promises to identify new genes critical to carcinogenesis and other biological processes.

Entities:  

Mesh:

Year:  2000        PMID: 10655046     DOI: 10.1038/72730

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  13 in total

1.  Virtual genome scan: a tool for restriction landmark-based scanning of the human genome.

Authors:  J M Rouillard; A E Erson; R Kuick; J Asakawa ; K Wimmer; M Muleris; E M Petty; S Hanash
Journal:  Genome Res       Date:  2001-08       Impact factor: 9.043

2.  RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration.

Authors:  Peng-Jin Mei; Jin Bai; Hui Liu; Chen Li; Yong-Ping Wu; Zheng-Quan Yu; Jun-Nian Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-16       Impact factor: 4.553

3.  Global analysis of methylation profiles from high resolution CpG data.

Authors:  Ni Zhao; Douglas A Bell; Arnab Maity; Ana-Maria Staicu; Bonnie R Joubert; Stephanie J London; Michael C Wu
Journal:  Genet Epidemiol       Date:  2014-12-23       Impact factor: 2.135

4.  Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily.

Authors:  G Steele-Perkins; W Fang; X H Yang; M Van Gele; T Carling; J Gu; I M Buyse; J A Fletcher; J Liu; R Bronson; R B Chadwick; A de la Chapelle; X Zhang; F Speleman; S Huang
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

5.  Phase I and pharmacologic study of the human DNA methyltransferase antisense oligodeoxynucleotide MG98 given as a 21-day continuous infusion every 4 weeks.

Authors:  Alison J Davis; Karen A Gelmon; Lillian L Siu; Malcolm J Moore; Carolyn D Britten; Nisha Mistry; Henry Klamut; Susan D'Aloisio; Martha MacLean; Nancy Wainman; Debbie Ayers; Patricia Firby; Jeffrey M Besterman; Gregory K Reid; Elizabeth A Eisenhauer
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850

6.  Identifying genes progressively silenced in preneoplastic and neoplastic liver tissues.

Authors:  Kellie J Archer; Zhongming Zhao; Tobias Guennel; Daniel G Maluf; Robert A Fisher; Valeria R Mas
Journal:  Int J Comput Biol Drug Des       Date:  2010-08-05

Review 7.  Clinical applications of urinary cell-free DNA in cancer: current insights and promising future.

Authors:  Tian Lu; Jinming Li
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

8.  Differential expression of bikunin (HAI-2/PB), a proposed mediator of glioma invasion, by demethylation treatment.

Authors:  James M Schuster; Maria Longo; Peter S Nelson
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

9.  Ordinal response prediction using bootstrap aggregation, with application to a high-throughput methylation data set.

Authors:  K J Archer; V R Mas
Journal:  Stat Med       Date:  2009-12-20       Impact factor: 2.373

10.  DNA methyltransferase 3B promoter polymorphism and its susceptibility to primary hepatocellular carcinoma in the Chinese Han nationality population: a case-control study.

Authors:  Ying Wu; Ju-Sheng Lin
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.